PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responses
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council (MR/P018513/1)
This publication has 42 references indexed in Scilit:
- Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterolJournal of Lipid Research, 2010
- High Blood Pressure in Acute Ischemic Stroke And Clinical OutcomeNeurology International, 2009
- Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1–dependent leukocyte recruitment in vivoJournal of Experimental Medicine, 2008
- Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitorsBlood, 2008
- PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 releaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- NK‐cell‐dependent acute xenograft rejection in the mouse heart‐to‐rat modelXenotransplantation, 2006
- Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endotheliumBlood, 2004
- Thrombin Induces Nitric-oxide Synthase via Gα12/13-coupled Protein Kinase C-dependent I-κBα Phosphorylation and JNK-mediated I-κBα DegradationJournal of Biological Chemistry, 2003
- Increased ABCA1 activity protects against atherosclerosisJournal of Clinical Investigation, 2002
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991